Soloviev Group CEO Michael Hershman Issues Statement Following Wednesday’s Community Advisory Committee Votes
NEW YORK, Sept. 17, 2025 /PRNewswire/ — In response to the September 17, 2025, Community Advisory Committee votes on Caesars Palace Times Square and The Avenir, Soloviev Group CEO Michael Hershman stated: “Our extensive planning process is reflective of input from neighbors, local leaders, and civic partners and considers how Freedom Plaza would not only […]
STRETCH ZONE OPENS NEWEST LOCATION IN BEDMINSTER, NJ
Helping Somerset County Residents Move Better, Feel Better, and Live Better BEDMINSTER, N.J., Sept. 17, 2025 /PRNewswire/ — Stretch Zone, the nation’s leading practitioner-assisted stretching brand, is proud to announce the grand opening of its newest studio in Bedminster Township, New Jersey. This marks the first location for owner Ray Kalustyan, with a second studio […]
Ballard to launch FCmove®-SC fuel cell at Busworld: improved performance and lifecycle cost on the road to diesel parity
New fuel cell engineered to power city transit buses – lower cost, simplified vehicle integration, smarter fleet services, and enhanced safety VANCOUVER, BC, Sept. 17, 2025 /PRNewswire/ – Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) will unveil its new-generation transit fuel cell module, the FCmove®-SC, at Busworld in Brussels on 4–9 October 2025. Designed for […]
WESTLAWN AMERICAS OFFSHORE ANNOUNCES NEW COUNTRY ENTRY WITH ACQUISITION OF WORKING INTEREST IN Z-61, Z-62, AND Z-63 BLOCKS OFFSHORE PERU
HOUSTON, Sept. 17, 2025 /PRNewswire/ — Westlawn Americas Offshore LLC (“WAO”), a portfolio company of the Westlawn Group (“Westlawn”), is pleased to announce the completion of a transaction in which it has acquired a 30% non-operated working interest in the Z-61, Z-62, and Z-63 blocks offshore Peru (the “Transaction”). The working interest was acquired pursuant […]
Bullish Reports Second Quarter 2025 Results
Bullish obtains New York DFS BitLicense, unlocking Q4’2025 US market entry Q2’2025 Digital asset sales of $58.6 billion and net income of $108.3 million Q2’2025 Adjusted Revenue of $57.0 million and Adjusted EBITDA of $8.1 million Q3’2025 Adjusted Revenue Guidance of $69.0 to $76.0 million and Adjusted EBITDA of $25.0 to $28.0 million CAYMAN ISLANDS, […]
LNTH INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, Sept. 17, 2025 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Lantheus Holdings, Inc. (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), have until November 10, 2025 to seek appointment as lead plaintiff of […]
M&T Bank Corporation Announces Third Quarter 2025 Earnings Release and Conference Call
BUFFALO, N.Y., Sept. 17, 2025 /PRNewswire/ — M&T Bank Corporation (“M&T”) (NYSE:MTB) plans to announce its third quarter 2025 earnings results in a press release that will be issued before the market opens on Thursday, October 16, 2025. Following the release, M&T will conduct a conference call and webcast at 11:00 a.m. (ET) to discuss […]
Ontario International Airport soars to #2 in J.D. Power’s 2025 North America Airport Satisfaction Study
ONTARIO, Calif., Sept. 17, 2025 /PRNewswire/ — Ontario International Airport (ONT) has climbed to new heights in the latest J.D. Power North America Airport Satisfaction StudySM, ranking No. 2 among all medium-sized airports in North America. The Southern California gateway advanced from fourth place in 2024, further cementing its reputation as one of the nation’s most passenger-friendly airports. Continue […]
EADV Congress 2025: GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients
PARIS, Sept. 18, 2025 /PRNewswire/ — Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% lower risk of major cardiovascular events compared to those taking other diabetes or weight-loss medications, new research has shown. The study – the largest of its kind and presented today […]
Congrès EADV 2025 : Les médicaments GLP-1RA réduisent considérablement la mortalité et le risque cardiovasculaire chez les patients atteints de psoriasis
PARIS, 18 septembre 2025 /PRNewswire/ — Les patients atteints de psoriasis traités par des agonistes du récepteur du peptide-1 de type glucagon (GLP-1RA) présentent un risque de décès réduit de 78 % et un risque d’événements cardiovasculaires majeurs réduit de 44 % par rapport à ceux qui prennent d’autres médicaments contre le diabète ou pour […]